Comprehensive NGS Solutions for Genome Editing Validation and Analysis

N2Jenomics Lab Pvt. Ltd. provides end-to-end CRISPR sequencing services powered by advanced Next-Generation Sequencing (NGS) technologies to help researchers accurately validate genome edits, evaluate editing efficiency, identify off-target events, and analyze large-scale CRISPR screening experiments. Our integrated sequencing and bioinformatics platform delivers high-resolution, publication-ready insights for applications spanning functional genomics, disease research, biotechnology, agriculture, and precision medicine.

Backed by a multidisciplinary team with expertise in both genome editing and NGS bioinformatics, we provide comprehensive scientific support from experimental planning to data interpretation, ensuring reliable and reproducible results for every project.

What is CRISPR?

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary genome editing technology adapted from the natural adaptive immune system of bacteria and archaea. In nature, microorganisms capture fragments of invading viral DNA and store them within specialized CRISPR regions. These stored sequences enable the organism to recognize and defend against future infections by directing CRISPR-associated (Cas) proteins to precisely target and cleave matching viral DNA.

Scientists have harnessed this natural defense mechanism to develop one of the most powerful genome engineering tools available today. By programming guide RNAs to recognize specific DNA sequences, CRISPR enables precise modification of virtually any gene, making it invaluable for biological research, biotechnology, agriculture, and therapeutic development.

Core Components of the CRISPR System

• CRISPR Arrays -  Genomic regions composed of repeated DNA sequences interspersed with spacer sequences derived from previous viral infections, serving as the genetic memory of the bacterial immune system.

• Cas Proteins -  CRISPR-associated nucleases, such as Cas9 and Cas12, that introduce highly specific DNA cleavage at targeted genomic locations.

• Guide RNA (gRNA/sgRNA) -  A synthetic RNA molecule designed to direct the Cas protein to a specific DNA sequence, enabling precise genome editing.

Together, these components enable targeted gene disruption, insertion, replacement, and precise nucleotide modifications.

What is the CRISPR-Cas9 System?

The CRISPR-Cas9 system is one of the most widely used genome editing technologies due to its simplicity, precision, and versatility. It employs two essential components:

• A single-guide RNA (sgRNA) that directs the editing machinery to the desired genomic location.
• The Cas9 nuclease, which introduces a targeted double-stranded DNA break at the specified site.

Following DNA cleavage, the cell's natural repair mechanisms generate the desired genetic modification. Depending on the repair pathway, researchers can create:

• • Gene knockouts
• • Gene knock-ins
• • Small insertions and deletions (InDels)
• • Point mutations
• • Targeted sequence replacements
• • Base editing and prime editing modifications

The flexibility and efficiency of CRISPR-Cas9 have transformed genome engineering across biomedical research, agriculture, synthetic biology, and drug discovery.

What is CRISPR Sequencing?

While CRISPR enables precise genome editing, confirming that the intended genetic changes have occurred requires equally precise analytical methods. CRISPR Sequencing combines genome editing with Next-Generation Sequencing (NGS) to accurately characterize editing outcomes at nucleotide resolution.

High-depth sequencing allows researchers to validate genome edits, quantify editing efficiency, identify unintended mutations, and assess editing specificity with exceptional sensitivity.

Our CRISPR sequencing services support a wide range of applications, including:

• • On-target edit validation.
• • Knock-in and knock-out confirmation.
• • Base editing and prime editing analysis.
• • Off-target mutation detection.
• • Guide RNA performance assessment.
• • Functional CRISPR screening.
• • Large-scale genome editing studies.

• Targeted amplicon sequencing remains one of the most sensitive approaches for validating CRISPR experiments, enabling the detection of low-frequency mutations that may be missed by conventional methods.

Why Choose N2Jenomics for CRISPR Sequencing?

To meet the growing demands of modern genome editing research, N2Jenomics Lab Pvt. Ltd. has developed a scalable, accurate, and cost-effective CRISPR sequencing platform that combines advanced sequencing technologies with specialized bioinformatics.

Our services provide detailed insights into genome editing outcomes, including:

• • Quantitative editing efficiency assessment.
• • Characterization of insertions, deletions, and substitutions.
• • Confirmation of knock-in and knock-out alleles.
• • Homozygous and heterozygous genotype determination.
• • Guide RNA performance evaluation.
• • Mutation frequency analysis.
• • Comprehensive visualization and publication-ready reports.

• From pilot studies to large-scale validation projects, our workflows are optimized for accuracy, reproducibility, and rapid turnaround.

Advantages of Our CRISPR Sequencing Services

Choosing the right sequencing partner is critical for successful genome editing research. Our integrated platform offers several advantages designed to maximize data quality and experimental confidence.

• High-Precision Genome Edit Validation

Accurately identify on-target genome edits with nucleotide-level resolution, enabling reliable confirmation of genome engineering outcomes.

• Support for Multiple Editing Strategies

Our workflows are compatible with diverse CRISPR technologies, including gene knockouts, knock-ins, base editing, prime editing, and multiplex genome editing.

• High-Throughput Processing

Process large numbers of samples efficiently using optimized sequencing workflows suitable for both small validation studies and high-throughput research projects.

• Ultra-Deep Sequencing Coverage

High sequencing depth enables sensitive detection of low-frequency variants and rare editing events with exceptional confidence.

• Sensitive and Cost-Effective Analysis

Our optimized protocols deliver reliable mutation detection while maintaining cost efficiency across a wide range of project sizes.

• Streamlined Experimental Workflow

NGS-based validation eliminates many labor-intensive validation methods, reducing overall project time while improving analytical resolution.

• Expert Scientific Support

Our experienced Ph.D.-level scientists provide guidance throughout the project, from experimental design and sequencing strategy selection to advanced bioinformatics analysis and data interpretation.

Applications of CRISPR Sequencing

Our CRISPR sequencing platform supports a broad spectrum of research areas across academia, biotechnology, agriculture, and translational medicine.

• Functional Genomics

• - Gene function studies.
• - Genome-wide CRISPR screening.
• - Gene interaction analysis.
• - Synthetic lethality research.
• - Pathway discovery.

• Gene and Cell Therapy Research

• - Validation of therapeutic genome editing.
• - Gene correction studies.
• - Safety assessment of genome editing.
• - Development of precision medicine approaches.

• Agricultural Biotechnology

• - Crop improvement.
• - Trait enhancement.
• - Disease resistance research.
• - Functional characterization of plant genes.
• - Livestock genome engineering.

• Cancer Research

• - Identification of cancer driver genes.
• - Functional screening of oncogenic pathways.
• - Drug resistance studies.
• - Biomarker discovery.
• - Target identification for therapeutic development.

• Additional Research Areas

• - Stem cell biology.
• - Immunology.
• - Neuroscience.
• - Infectious disease research.
• - Synthetic biology.
• - Regenerative medicine.

CRISPR Sequencing Workflow

Our standardized workflow is designed to generate accurate, reproducible, and publication-ready results while maintaining rigorous quality control throughout every stage of the project.

Step 1: Sample Preparation

High-quality genomic DNA is extracted and assessed to ensure suitability for downstream sequencing.

Step 2: Target Amplification

Regions of interest are amplified using optimized PCR protocols to generate sequencing-ready libraries with high specificity.

Step 3: Library Preparation & NGS

Sequencing libraries are prepared and analyzed using advanced Next-Generation Sequencing platforms, generating high-depth sequence data for comprehensive mutation analysis.

Step 4: Bioinformatics Analysis

Our dedicated analysis pipeline includes:

• • Quality assessment and read filtering.
• • Reference genome alignment.
• • InDel and variant detection.
• • Editing efficiency calculation.
• • Allele frequency estimation.
• • Off-target analysis (if applicable).
• • Functional screening analysis (for pooled CRISPR studies).
• • Publication-quality visualization and reporting.

Step 5: Results Delivery

Researchers receive a complete data package that includes:

• • Raw sequencing data (FASTQ files).
• • Processed alignment files (BAM/SAM).
• • Variant reports.
• • Editing efficiency summaries.
• • Publication-ready figures.
• • Comprehensive bioinformatics reports with scientific interpretation.

Service Specifications

	Sample Requirements Samples types: cell or DNA samples after CRISPR-Cas gene editing manipulation DNA sample: ~1 μg (concentration ≥ 30 ng/μl; OD260/280=1.8~2.0) Cell sample: 1×106 cells or 10 cm2 cell culture The sample preparation procedures cover DNA isolation, purification, quantification, QC, etc. Note: Sample amounts are listed for reference only. For detailed information, please contact us with your customized requests.
	Sequencing Strategy Illumina HiSeq platforms, paired-end 150 bp or 300 bp; PacBio's SMRT platform Sequencing depth: ≥ 1000x Analysis of sequencing quality metrics
	Bioinformatics Analysis We provide multiple customized bioinformatics analyses: Raw data QC Reference alignment Validation of CRISPR libraries Analysis of target loci Analysis of predicted off-target loci Note: Recommended data outputs and analysis contents displayed are for reference only. For detailed information, please contact us with your customized requests.

Analysis Pipeline

Deliverables

• The original sequencing data
• • Experimental results
• • Data analysis report
• • Details in CRISPR Sequencing for your writing (customization)

1. Is CRISPR-Cas9 a Next-Generation Sequencing (NGS) technology?

No. CRISPR-Cas9 and Next-Generation Sequencing (NGS) are complementary technologies that serve different purposes. CRISPR-Cas9 is a genome editing tool used to introduce targeted genetic modifications, while NGS is a high-throughput sequencing technology used to analyze and validate those modifications. Researchers commonly use NGS to confirm on-target edits, measure editing efficiency, detect off-target mutations, and characterize genome editing outcomes with high sensitivity and accuracy.

2. Why is NGS important for CRISPR experiments?

NGS provides comprehensive, high-resolution analysis of genome editing results that cannot be achieved with conventional validation methods alone. It enables researchers to quantify insertions and deletions (InDels), identify single nucleotide variants (SNVs), evaluate editing efficiency, detect low-frequency mutations, assess off-target effects, and validate knock-in or knock-out events. This detailed analysis ensures confidence in genome editing experiments and supports reliable downstream research.

3. How do researchers ensure accurate CRISPR sequencing results?

Accurate CRISPR sequencing relies on high-quality sequencing data combined with robust bioinformatics analysis. Specialized analytical pipelines align sequencing reads to a reference genome, identify genuine editing events, filter sequencing artifacts, and quantify mutation frequencies. In some studies, additional validation methods such as Sanger sequencing or droplet digital PCR (ddPCR) may be used to confirm specific variants and further strengthen the reliability of the results.

4. What are the ethical considerations associated with CRISPR sequencing?

While CRISPR sequencing itself is an analytical technology, it is often used in studies involving genome editing, which raises important ethical considerations. Researchers must carefully evaluate potential off-target effects, ensure responsible use of gene-editing technologies, comply with institutional and regulatory guidelines, obtain appropriate informed consent for human studies, and maintain transparency throughout the research process. These practices help promote safe, ethical, and scientifically responsible genome editing research.

5. How is CRISPR sequencing used in clinical and translational research?

CRISPR sequencing plays a critical role in the development of gene and cell therapies by validating genome edits and assessing their safety before clinical application. Researchers use NGS to confirm therapeutic gene modifications, evaluate editing precision, detect unintended genomic changes, and monitor genome integrity in engineered cells. It also supports the discovery of disease mechanisms, biomarker identification, and therapeutic target validation, helping accelerate the development of precision medicine and next-generation genetic therapies.